Fernando Ulloa‐Montoya

1.6k citations

18 papers · 1.1k indexed · h-index 12

Molecular Biology
Genetics top 2%
Surgery top 10%
Oncology top 10%
Immunology top 10%

Co-authors: Catherine M. Verfaillie Valerie D. Roobrouck Wei‐Shou Hu Lucas G. Chase Bart Spiessens Benjamin L. Kidder Benjamin Dizier Jamila Louahed
Topics: Immunotherapy and Immune Responses (6 papers)Pluripotent Stem Cells Research (5 papers)Cancer Immunotherapy and Biomarkers (4 papers)
Cited by: Genetics Immunology Oncology
Journals: Journal of Clinical Oncology Nature Biotechnology Diabetes
Partner nations: Belgium United States Netherlands

In The Last Decade

Fernando Ulloa‐Montoya

17 papers receiving 1.1k citations

Peers

Countries citing papers authored by Fernando Ulloa‐Montoya

Since Specialization

Citations

This map shows the geographic impact of Fernando Ulloa‐Montoya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Ulloa‐Montoya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Ulloa‐Montoya more than expected).

Fields of papers citing papers by Fernando Ulloa‐Montoya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Ulloa‐Montoya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Ulloa‐Montoya. The network helps show where Fernando Ulloa‐Montoya may publish in the future.

Co-authorship network of co-authors of Fernando Ulloa‐Montoya

This figure shows the co-authorship network connecting the top 25 collaborators of Fernando Ulloa‐Montoya. A scholar is included among the top collaborators of Fernando Ulloa‐Montoya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando Ulloa‐Montoya. Fernando Ulloa‐Montoya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Predicting the translation efficiency of messenger RNA in mammalian cells 2025 ·Nature Biotechnology ·Dinghai Zheng,(unknown),Jun Wang,Yue Liu,Fernando Ulloa‐Montoya,Can Cenik,Vikram Agarwal	4
2	A detailed analysis of possible efficacy signals of NTHi-Mcat vaccine against severe COPD exacerbations in a previously reported randomised phase 2b trial 2022 ·Vaccine ·Ashwani Kumar Arora,Kenneth Chinsky,Claus Keller,Irvin Mayers,Sergi Pascual-Guàrdia,(unknown),Christophe Lambert,(unknown),Simona Rondini,(unknown),Fernando Ulloa‐Montoya,(unknown),Daniela Casula	4
3	Subclass and avidity of circumsporozoite protein specific antibodies associate with protection status against malaria infection 2021 ·npj Vaccines ·Kelly E. Seaton,Rachel L. Spreng,(unknown),(unknown),(unknown),(unknown),(unknown),Sheetij Dutta,(unknown),S. Munir Alam,(unknown),Erik Jongert,Margherita Coccia,Fernando Ulloa‐Montoya,Ulrike Wille-Reece,Georgia D. Tomaras,S. Moses Dennison	13
4	Transcriptional profiles of adjuvanted hepatitis B vaccines display variable interindividual homogeneity but a shared core signature 2020 ·Science Translational Medicine ·Laurane De Mot,Viviane Bechtold,Vanesa Bol,Andrea Callegaro,Margherita Coccia,Ahmed Essaghir,(unknown),Fernando Ulloa‐Montoya,Emilio Siena,Age K. Smilde,Robert A. van den Berg,Arnaud M. Didierlaurent,Wivine Burny,Robbert van der Most	33
5	A Th1/IFNγ Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non–Small Cell Lung Cancer 2019 ·Clinical Cancer Research ·Benjamin Dizier,Andrea Callegaro,Muriel Debois,Brigitte Dréno,Peter Hersey,Helen Gogas,John M. Kirkwood,Johan Vansteenkiste,Lecia V. Sequist,Djordje Atanackovic,Jelle J. Goeman,Hans C. van Houwelingen,Susana Alicia Salceda,(unknown),Patrick Therasse,C. Debruyne,Bart Spiessens,Vincent Brichard,Jamila Louahed,Fernando Ulloa‐Montoya	13
6	Association of homogeneous inflamed gene signature with a better outcome in patients with metastatic melanoma treated with MAGE-A3 immunotherapeutic 2018 ·ESMO Open ·Jean‐François Baurain,Caroline Robert,Laurent Mortier,Bart Neyns,Florent Grange,Célèste Lebbé,Fernando Ulloa‐Montoya,(unknown),Marc Gillet,Jamila Louahed,(unknown),Frédéric Lehmann	1
7	A Predictive Enrichment Procedure to Identify Potential Responders to a New Therapy for Randomized, Comparative Controlled Clinical Studies 2015 ·Biometrics ·Junlong Li,Lihui Zhao,Lü Tian,Tianxi Cai,Brian Claggett,Andrea Callegaro,Benjamin Dizier,Bart Spiessens,Fernando Ulloa‐Montoya,L. J. Wei	31
8	Predictive Gene Signature in MAGE-A3 Antigen-Specific Cancer Immunotherapy 2013 ·Journal of Clinical Oncology ·Fernando Ulloa‐Montoya,Jamila Louahed,Benjamin Dizier,Olivier Gruselle,Bart Spiessens,Frédéric Lehmann,Stefan Suciu,Wim H.J. Kruit,Alexander M.M. Eggermont,Johan Vansteenkiste,Vincent Brichard	290
9	Differentiation Potential of Human Postnatal Mesenchymal Stem Cells, Mesoangioblasts, and Multipotent Adult Progenitor Cells Reflected in Their Transcriptome and Partially Influenced by the Culture Conditions 2011 ·Stem Cells ·Valerie D. Roobrouck,Carlos Clavel,Sandra Jacobs,Fernando Ulloa‐Montoya,Stefania Crippa,Abhishek Sohni,Scott J. Roberts,Frank P. Luyten,Stefaan W. Van Gool,Maurilio Sampaolesi,Michel Delforge,Aernout Luttun,Catherine M. Verfaillie	132
10	Isolation Procedure and Characterization of Multipotent Adult Progenitor Cells from Rat Bone Marrow 2010 ·Methods in molecular biology ·Kartik Subramanian,Martine Geraerts,Karen Pauwelyn,(unknown),(unknown),Manja Muijtjens,Fernando Ulloa‐Montoya,(unknown),Catherine M. Verfaillie,Wei Hu	29
11	Maintenance of HSC by Wnt5a secreting AGM-derived stromal cell line 2010 ·Experimental Hematology ·Shannon M. Buckley,Fernando Ulloa‐Montoya,(unknown),Robert A.J. Oostendorp,Elaine Dzierzak,Stephen C. Ekker,Catherine M. Verfaillie	27
12	Breast cancer resistance protein 1 (bcrp) and p-glycoprotein (mdr1) are key players in renal regeneration after ischemic injury 2009 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Miriam Huls,Fernando Ulloa‐Montoya,Aernout Luttun,Aswin Menke,(unknown),Rob Woestenenk,(unknown),Frans G. M. Rüssel,Catherine M. Verfaillie,Rosalinde Masereeuw	1
13	Clinical Activity Following the Administration of the MAGE-A3 Antigen-specific Cancer Immunotherapeutic in Both the Melanoma and NSCLC is Associated With Similar Predictive Biomarkers Present Prior Treatment 2009 ·Frédéric Lehmann,Fernando Ulloa‐Montoya,Olivier Gruselle,Benjamin Dizier,Jamila Louahed,Johan Vansteenkiste,Alan Spatz,(unknown),(unknown)	2
14	Abstract A37: Identification of a gene expression signature predictive of clinical activity following MAGE-A3 ASCI treatment 2009 ·Molecular Cancer Therapeutics ·Jamila Louahed,Frédéric Lehmann,Fernando Ulloa‐Montoya,Olivier Gruselle,Benjamin Dizier,Johan Vansteenkiste,Wim H.J. Kruit,Vincent Brichard	0
15	Self-renewal and differentiation capacity of young and aged stem cells 2008 ·Experimental Cell Research ·Valerie D. Roobrouck,Fernando Ulloa‐Montoya,Catherine M. Verfaillie	212
16	Comparative transcriptome analysis of embryonic and adult stem cells with extended and limited differentiation capacity 2007 ·Genome biology ·Fernando Ulloa‐Montoya,Benjamin L. Kidder,Karen Pauwelyn,Lucas G. Chase,Aernout Luttun,(unknown),Martine Geraerts,Alexei A. Sharov,Yulan Piao,Minoru S.H. Ko,Wei‐Shou Hu,Catherine M. Verfaillie	105
17	Islet-Derived Fibroblast-Like Cells Are Not Derived via Epithelial-Mesenchymal Transition From Pdx-1 or Insulin-Positive Cells 2006 ·Diabetes ·Lucas G. Chase,Fernando Ulloa‐Montoya,Benjamin L. Kidder,Catherine M. Verfaillie	83
18	Culture systems for pluripotent stem cells 2005 ·Journal of Bioscience and Bioengineering ·Fernando Ulloa‐Montoya,Catherine M. Verfaillie,Wei‐Shou Hu	113

About Fernando Ulloa‐Montoya

Fernando Ulloa‐Montoya is a scholar working on Immunology, Genetics and Virology, having authored 18 papers that have together received 1.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), Pluripotent Stem Cells Research (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Genetics (363 citations), Immunology (254 citations) and Oncology (269 citations). Fernando Ulloa‐Montoya has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Catherine M. Verfaillie, Valerie D. Roobrouck, Wei‐Shou Hu, Lucas G. Chase, Bart Spiessens, Benjamin L. Kidder, Benjamin Dizier, Jamila Louahed, Frédéric Lehmann and Olivier Gruselle. Their work appears in journals such as Journal of Clinical Oncology, Nature Biotechnology and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact